Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Board and Management Restructuring

10 Aug 2023 07:00

RNS Number : 8597I
Tern PLC
10 August 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018). UPON THE PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN.

 

10 August 2023

 

Tern Plc

 

("Tern" or the "Company")

Board and Management Restructuring

Directorate Changes

Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, announces a number of changes to the board of the Company (the "Board") and the Company's management structure.

 

Matthew Scherba and Bruce Leith have both stepped down from the Board with immediate effect. Matthew Scherba, having been on secondment to Tern's portfolio company InVMA Limited, intends to transition to the full time Chief Executive Officer position at Konektio during August 2023. Bruce Leith will remain with Tern as an employee and a member of its senior management team.

 

Sarah Payne will step down as the Company's Chief Financial Officer and Company Secretary on or before 30 September 2023 to take up a position with another company, but will remain on the Board as a Non-Executive Director. A further announcement will be made when this change occurs. The Company expects to shortly appoint a part-time Chief Financial Officer, which will be a non-Board position.

 

Following these changes, the Board of the Company will comprise: Ian Ritchie (Non-executive Chairman), Alan Howarth (Senior Independent Non-Executive Director) and Sarah Payne (Non-executive Director).

 

The Board will be supported by a non-Board senior executive management team comprising: Al Sisto (as Chief Executive Officer), Bruce Leith and a part-time Chief Financial Officer. The senior management team will receive materially reduced remuneration from the levels they received when members of the Board.

 

In addition, the Company is implementing other cost saving measures, including moving to a lower cost office. However, the Company will continue to be required to incur legal and other professional fees associated with the portfolio companies and being an AIM quoted company at least at historic levels, before any additional professional costs, in particular legal costs, incurred in relation with the disposal of any portfolio company holding. Overall, the measures being implemented are expected to save approximately 40% of the Company's overall central costs in 2024, when compared to the level for 2022.

 

No compensation is being paid to any individual for loss of office or the change in their role. Additionally, on the disposal of Tern's holding in any of its portfolio companies the Board has resolved that no more that 10% of the net disposal proceeds will be available for additional Board, management or employee remuneration.

 

This Board and management restructuring is intended to provide an appropriate governance and management structure for the Company, at significantly reduced cost, as the Company seeks to realise value from its portfolio of IoT technology businesses. It is the Board's intention that the Company will not invest in any companies or entities not already part of Tern's existing portfolio until such time as the Company has realised material value from its current portfolio companies.

 

The Company expects to release its interim results for the six months ended 30 June 2023 before the end of August 2023.

 

Commenting, Ian Ritchie, Non-executive Chairman, said: "We recognise the desire of shareholders to see a reduction in Tern's central costs whilst maintaining our hands on approach with our investee companies and focussing on realising value from them. The restructuring we are announcing today, together with other measures we are taking, is designed to significantly reduce our overheads whilst we look to deliver value to our shareholders from the Company's investments.

 

"It is my role as Chairman to ensure that the Board acts independently and in the interests of all shareholders. I am delighted that we are retaining the services of Sarah Payne as a Non-Executive Director as her skills and experience of Tern will be invaluable as we seek to maximise shareholder returns from our portfolio of exciting IoT businesses. I look forward to continuing to work with Sarah, Tern's Senior Independent Non-executive Director, Alan Howarth, and the senior management team of Al Sisto and Bruce Leith, coupled with our new part time CFO (once appointed). This is a team that has a deep understand of Tern's portfolio companies and their markets and I believe is best placed to ensure that maximum value is extracted from them, continuing our hands on approach, in order for Tern to be able to deliver returns to its shareholders.

 

"I would also like to take this opportunity to thank Matthew Scherba for his contribution to Tern over the past four years and we wish him well in his new role at Konektio. We are sure that he will be focussed hard on driving the value of Konektio and maximising the return to Tern as a shareholder in the business.

 

"Our portfolio companies continue to perform well as leaders in their categories and we look forward to providing a further update with the release of our interim results later this month."

 

Enquiries

 

Tern Plc

Ian Ritchie (Non-executive Chairman)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Dan Dearden-Williams (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASSFFAUEDSEFA
Date   Source Headline
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.